Prognostic Significance of Programmed Cell Death-1, Programmed Cell Death-Ligand 1, Programmed Cell Death-Ligand 2, and Fibroblast Growth Factor Receptor 3 mRNA Expression in Bladder Cancer
Our findings suggest that elevated levels of PD-1, PD-L1, and PD-L2, combined with reduced FGFR3 expression, may assist in identifying patients with poor outcomes and highlight their potential as prognostic biomarkers in BC.
Authors
- Enrique Gómez‐Gómez (ORCID: https://orcid.org/0000-0002-8753-3306)
- J.P. Campos-Hernández (ORCID: https://orcid.org/0000-0002-9994-5754)
- Ana Blanca (ORCID: https://orcid.org/0000-0002-4360-4352)
- Rodolfo Montironi (ORCID: https://orcid.org/0000-0003-3938-610X)
- Alessia Cimadamore (ORCID: https://orcid.org/0000-0001-5981-3514)
- Liang Cheng (ORCID: https://orcid.org/0000-0001-6049-5293)
- Antonio López-Beltrán (ORCID: https://orcid.org/0000-0003-3161-8164)
Institutions
- Marche Polytechnic University (IT)
- University of Udine (IT)
- Brown University (US)
- Instituto Maimónides de Investigación Biomédica de Córdoba (ES)
- Hospital Universitario Reina Sofía (ES)
- University of Córdoba (ES)
Publication Details
- Journal
- Pathobiology
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1159/000544733
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00